loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2008_210___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Taizhou Highsun Pharmaceutical Co.,Ltd.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TAIZHOU HIGHSUN PHARMACEUTICAL CO., LTD. Duqiao CN (1)

    filter

    01 Glipizide (1)

    filter

    01 China (1)

    filter

    01 Withdrawn by EDQM Failure to CEP procedure (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    TAIZHOU HIGHSUN PHARMACEUTICAL CO.,...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Glipizide

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2008-210 - Rev 00
      Withdrawn by EDQM F...
      Chemical
      2015-02-17
      2021-09-23
      906
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-210 - Rev 00 of Taizhou Highsun Pharmaceutical Co., Ltd. Duqiao Cn

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-210 - Rev 00 of Taizhou Highsun Pharmaceutical Co., Ltd. Duqiao Cn 1

      20

      Taizhou Highsun Pharmaceutical Co., Ltd. Duqiao Cn, based in China, is a pharmaceutical company.

      One of their significant offerings is Glipizide, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2008-210 - Rev 00

      This Chemical Type CEP, issued on February 17, 2015, remains in force until September 23, 2021, ensuring its reliability within the pharmaceutical industry.

      Substance Number 906 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY